Pharmacogenomics and hypertension: current insights (2019)
- Authors:
- USP affiliated authors: SANTOS, JOSE EDUARDO TANUS DOS - FMRP ; LACCHINI, RICCARDO - EERP ; PEREIRA, SHERLIANE CARLA - FMRP
- Unidades: FMRP; EERP
- DOI: 10.2147/PGPM.S230201
- Subjects: GENES; HIPERTENSÃO; FARMACOGENÉTICA
- Keywords: Antihypertensive therapy; Candidate genes; GWAS; Gene-gene interactions; Hypertension; Pharmacogenomics
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher place: Macclesfield
- Date published: 2019
- Source:
- Título: Pharmacogenomics and Personalized Medicine
- ISSN: 1178-7066
- Volume/Número/Paginação/Ano: v. 2019, n. 12, p. 341-359, 2019
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by-nc
-
ABNT
OLIVEIRA-PAULA, Gustavo H. et al. Pharmacogenomics and hypertension: current insights. Pharmacogenomics and Personalized Medicine, v. 2019, n. 12, p. 341-359, 2019Tradução . . Disponível em: https://doi.org/10.2147/PGPM.S230201. Acesso em: 25 abr. 2025. -
APA
Oliveira-Paula, G. H., Pereira, S. C., Tanus-Santos, J. E., & Lacchini, R. (2019). Pharmacogenomics and hypertension: current insights. Pharmacogenomics and Personalized Medicine, 2019( 12), 341-359. doi:10.2147/PGPM.S230201 -
NLM
Oliveira-Paula GH, Pereira SC, Tanus-Santos JE, Lacchini R. Pharmacogenomics and hypertension: current insights [Internet]. Pharmacogenomics and Personalized Medicine. 2019 ; 2019( 12): 341-359.[citado 2025 abr. 25 ] Available from: https://doi.org/10.2147/PGPM.S230201 -
Vancouver
Oliveira-Paula GH, Pereira SC, Tanus-Santos JE, Lacchini R. Pharmacogenomics and hypertension: current insights [Internet]. Pharmacogenomics and Personalized Medicine. 2019 ; 2019( 12): 341-359.[citado 2025 abr. 25 ] Available from: https://doi.org/10.2147/PGPM.S230201 - Interethnic differences in the distribution of matrix metalloproteinases genetic polymorphisms are consistent with interethnic differences in disease prevalence
- Clinical and pharmacogenetic impact of endothelial nitric oxide synthase polymorphisms on cardiovascular diseases
- Increased activity of MMP-2 in hypertensive obese children is associated with hypoadiponectinemia
- The effects of NAMPT haplotypes and metabolic risk factors on circulating visfatin/NAMPT levels in childhood obesity
- Endothelial nitric oxide synthase: from biochemistry and gene structure to clinical implications of NOS3 polymorphisms
- Matrix metalloproteinase (MMP)-2 genetic variants modify the circulating MMP-2 levels in end-stage kidney disease
- Common matrix metalloproteinase 2 gene haplotypes may modulate left ventricular remodelling in hypertensive patients
- Effect of genetic polymorphisms of vascular endothelial growth factor on left ventricular hypertrophy in patients with systemic hypertension
- Polymorphisms in VEGFA gene affect the antihypertensive responses to enalapril
- Plasma levels of matrix metalloproteinase-9 are elevated in individuals with hypertensive crisis
Informações sobre o DOI: 10.2147/PGPM.S230201 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
003008694.pdf | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
